drugset / Trial / NCT00163280
Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This purpose of this study is to investigate whether ATL-104 is safe and well tolerated, and whether it shows evidence of efficacy in mucositis in patients undergoing PBSCT
Timeline
- Start
- 2004-07
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ATL-104 | Unknown | 50 mg | Oral |
| Subject | ATL-104 | Unknown | 100 mg | Oral |
| Subject | ATL-104 | Unknown | 150 mg | Oral |